AUDUBON, PA — Globus Medical Inc. (NYSE: GMED) raised its full-year profit outlook after second-quarter revenue climbed 5.9% to $789.6 million, with stronger spine sales and margin expansion offsetting a year-over-year decline in GAAP earnings tied to a one-time acquisition gain recorded in 2025.
The musculoskeletal technology company now expects 2026 non-GAAP diluted earnings per share of $4.95 to $5.05, up from its previous range of $4.70 to $4.80. Globus reaffirmed full-year revenue guidance of $3.18 billion to $3.22 billion.
Second-quarter GAAP net income fell 25.3% to $151.6 million, while diluted EPS declined 26.2% to $1.10 from $1.49 a year earlier.
The comparison was distorted by a $110.5 million bargain-purchase gain recognized in the second quarter of 2025 related to the Nevro acquisition.
On a non-GAAP basis, diluted EPS rose 55.8% to $1.34 from $0.86.
Worldwide revenue increased 5.9% as reported and 5.6% on a constant-currency basis. Excluding Nevro, management reported 9% revenue growth.
U.S. sales rose 3%, while international sales increased 18% as reported and 16.2% on a constant-currency basis.
Chief Executive Officer Keith Pfeil pointed to U.S. Spine and International Spine as the strongest contributors, with U.S. Spine revenue up 7% and International Spine up 14% as reported, or 12% at constant currency.
“Momentum continued into the second quarter with 6% overall revenue growth, or 9% growth excluding Nevro,” Pfeil said.
The company also reported a 200-basis-point expansion in adjusted gross margin from a year earlier.
Chief Financial Officer Kyle Kline said the combination of revenue growth, margin expansion, operating leverage and acquisition synergies produced record second-quarter non-GAAP net income and diluted EPS.
Globus is continuing to integrate Nevro while emphasizing its spine and surgical technology portfolio as a core source of growth.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.